Development and validation of a method for determination of Eculizumab concentration in human plasma by biolayer interferometry

Development and validation of a method for determination of Eculizumab concentration in human plasma by biolayer interferometry

The article describes a new method for measurement of monoclonal antibody Eculizumab concentration in human plasma in a range of 3-250 μg/ml. In this method we used an antibody Fab fragment, capable of binding to eculizumab specifically in human plasma. The method uses the biolayer interferometry fo...

Full description

Bibliographic Details
Main Authors:	V. M. Simonov, M. S. Pantushenko, A. A. Kazarov, O. A. Markova, G. N. Poroshin
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	моноклональное антитело экулизумаб биослойная интерферометрия валидация monoclonal antibody eculizumab biolayer interferometry validation
Online Access:	https://www.biopreparations.ru/jour/article/view/98

Similar Items

Development and Validation of a Biolayer Interferometry Method for Determination of Human Anti-PD-1 Monoclonal Antibody Concentration in Cynomolgus Serum
by: K. V. Ulyanova, et al.
Published: (2020-12-01)

Method development and validation for determination of antihemolytic activity of eculizumab (Soliris)
by: E. Yu. Prudnikova, et al.
Published: (2017-03-01)

Measuring the effects of macromolecular crowding on antibody function with biolayer interferometry
by: Dorothy M. Kim, et al.
Published: (2019-10-01)

Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)
by: V. I. Mazurov, et al.
Published: (2021-08-01)

Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry
by: Qingqing Chen, et al.
Published: (2022-08-01)

On-Site Biolayer Interferometry-Based Biosensing of Carbamazepine in Whole Blood of Epileptic Patients
by: Sumin Bian, et al.
Published: (2021-12-01)

2LTRZFP Interacts Specifically to HIV-1 DNA without Off-Target Effects as Determined by Biolayer Interferometry
by: Koollawat Chupradit, et al.
Published: (2021-03-01)

Applications of Surface Plasmon Resonance and Biolayer Interferometry for Virus–Ligand Binding
by: Shruthi Murali, et al.
Published: (2022-03-01)

The first results of combined treatment of giant cell tumor of bone
by: A. A. Barashev, et al.
Published: (2020-11-01)

Experience of the Successful Treatment With Canakinumab of a Patient With Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

The study of cross-reactivity of therapeutic drugs based on monoclonal antibodies on human tissues: basic approaches and methodological techniques
by: T. Y. Ostroukhova, et al.
Published: (2018-02-01)

High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS
by: Minsong Guo, et al.
Published: (2022-04-01)

A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody
by: Sunil Gairola, et al.
Published: (2020-08-01)

Selection, Characterization, and Optimization of DNA Aptamers against Challenging Marine Biotoxin Gymnodimine-A for Biosensing Application
by: Xiaojuan Zhang, et al.
Published: (2022-03-01)

Metabolomic Profiling of Biolayers on the Surface of Marble in Nature and Urban Environment. Case Study of Karelia and St. Petersburg
by: Katerina V. Sazanova, et al.
Published: (2021-09-01)

Human Astrovirus 1–8 Seroprevalence Evaluation in a United States Adult Population
by: Lena Meyer, et al.
Published: (2021-05-01)

Comparison of Enzyme-Linked Immunosorbent Assay, Surface Plasmon Resonance and Biolayer Interferometry for Screening of Deoxynivalenol in Wheat and Wheat Dust
by: Melanie Sanders, et al.
Published: (2016-04-01)

Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports
by: Hassib Chehade, et al.
Published: (2021-07-01)

Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
by: A. Amendola, et al.
Published: (2021-04-01)

Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring
by: Tyler Brady, et al.
Published: (2022-10-01)

Characterization of antibody-antigen interactions using biolayer interferometry
by: Tal Noy-Porat, et al.
Published: (2021-12-01)

Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022-12-01)

Transplant-associated Thrombotic Microangiopathy Treated with Eculizumab and Romiplostim
by: Muhammad Awidi, et al.
Published: (2021-02-01)

Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
by: Al-Ani F, et al.
Published: (2016-08-01)

Polymorpnism and multifunctionality of blood group antigens
by: E A Ryskina, et al.
Published: (2011-12-01)

Deciphering the Binding of the Nuclear Localization Sequence of Myc Protein to the Nuclear Carrier Importin α3
by: Bruno Rizzuti, et al.
Published: (2022-12-01)

A Rapid and Sensitive Aptamer-Based Biosensor for Amnesic Shellfish Toxin Domoic Acid
by: Luming Zhao, et al.
Published: (2022-11-01)

A Sulfated Abalone Polysaccharide Inhibited SARS-CoV-2 Infection of Vero E6 Cells In Vitro
by: Jinghe Sun, et al.
Published: (2022-09-01)

Modulation of HIV-1 capsid multimerization by sennoside A and sennoside B via interaction with the NTD/CTD interface in capsid hexamer
by: Da-Wei Zhang, et al.
Published: (2023-09-01)

A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer
by: Da-Wei Zhang, et al.
Published: (2023-02-01)

BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody
by: Jong Rip Choi, et al.
Published: (2020-06-01)

Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein
by: Kohei Yumoto, et al.
Published: (2021-11-01)

APPLICATION OF LASER PHOTONICS METHODS IN ORTHOPEDIC DENTISTRY FOR NON-INVASIVE NON-CONTACT EXAMINATION OF BULK MICRO-DEFORMATIONS OF BONE TISSUE
by: M. A. Grossmann, et al.
Published: (2018-06-01)

Eculizumab as Additional Rescue Therapy in Myasthenic Crisis
by: Francesco Crescenzo, et al.
Published: (2024-02-01)

Eculizumab‐related drug reaction in a patient with neuromyelitis optica
by: Rishi Sharma, et al.
Published: (2023-02-01)

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option
by: Elena Román, et al.
Published: (2017-09-01)

Antidiabetic effects and mechanisms of Cyclocarya paliurus leaf flavonoids via PIK3CA
by: Yanjun Wang, et al.
Published: (2024-02-01)

Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
by: Michael J. Fassett, et al.
Published: (2021-04-01)

NEPHROPATHIES ASSOCIATED WITH COMPLEMENT SYSTEM PATHOLOGY
by: V. V. Dlin, et al.
Published: (2017-01-01)

Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report
by: Tuan Vu, et al.
Published: (2021-02-01)